Aldeyra Therapeutics, Inc.
ALDX
$1.52
-$0.03-1.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 45.09M | 65.00M | 70.04M | 75.30M | 81.92M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.66M | 375.50K | 699.10K | 1.03M | 1.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 628.70K | 896.00K | 1.04M | 1.13M | 1.42M |
| Total Current Assets | 47.38M | 66.27M | 71.78M | 77.46M | 84.56M |
|
|
|||||
| Total Current Assets | 47.38M | 66.27M | 71.78M | 77.46M | 84.56M |
| Net Property, Plant & Equipment | 161.70K | 209.30K | 275.90K | 341.00K | 404.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 47.54M | 66.48M | 72.06M | 77.80M | 84.96M |
|
|
|||||
| Total Accounts Payable | 137.50K | 141.40K | 158.50K | 13.40K | 1.46M |
| Total Accrued Expenses | 3.37M | 2.67M | 6.12M | 7.00M | 6.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 143.40K | 15.51M | 15.53M | 15.47M | 15.41M |
| Total Finance Division Other Current Liabilities | 6.00M | 6.00M | 6.00M | 6.00M | 6.00M |
| Total Other Current Liabilities | 6.00M | 6.00M | 6.00M | 6.00M | 6.00M |
| Total Current Liabilities | 9.66M | 24.33M | 27.81M | 28.48M | 29.53M |
|
|
|||||
| Total Current Liabilities | 9.66M | 24.33M | 27.81M | 28.48M | 29.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 72.50K | 143.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.66M | 24.33M | 27.81M | 28.56M | 29.67M |
|
|
|||||
| Common Stock & APIC | 530.75M | 529.57M | 528.21M | 526.74M | 525.11M |
| Retained Earnings | -492.86M | -487.41M | -483.96M | -477.50M | -469.81M |
| Treasury Stock & Other | -- | -- | -- | 800.00 | -11.00K |
| Total Common Equity | 37.89M | 42.16M | 44.25M | 49.24M | 55.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.89M | 42.16M | 44.25M | 49.24M | 55.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.89M | 42.16M | 44.25M | 49.24M | 55.29M |
|
|
|||||